{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:37:27Z","timestamp":1794310647482,"version":"4.9.0"},"reference-count":86,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pheochromocytomas are rare neuroendocrine tumors with a highly variable clinical presentation, but they most commonly present as spells of headaches, sweating, palpitations, and hypertension. Patients with pheochromocytoma may develop complicated and potentially lethal cardiovascular and other complications, especially in the setting of diagnostic or interventional procedures (e.g. upon induction of anesthesia or during surgery). The serious and potentially lethal nature of such complications is due to the potent effect of paroxysmal release of catecholamines. Because this warrants prompt diagnosis and treatment, the physician should be aware of the clinical manifestations and complications of catecholamine excess and be able to provide proper preoperative management to minimize catecholamine-related pre-, intra-, and postoperative adverse events. The following clinical scenario and discussion aim to enhance the knowledge of the physician regarding the behavior of pheochromocytoma and to outline current approaches to comprehensive preoperative management of patients suffering from this tumor.<\/jats:p>","DOI":"10.1210\/jc.2007-1720","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T13:38:47Z","timestamp":1194442727000},"page":"4069-4079","source":"Crossref","is-referenced-by-count":484,"title":["Preoperative Management of the Pheochromocytoma Patient"],"prefix":"10.1210","volume":"92","author":[{"given":"Karel","family":"Pacak","sequence":"first","affiliation":[{"name":"Section on Medical Neuroendocrinology, Reproductive and Adult Endocrinology Program, National Institute of Child Health and Human Development, National Institutes of Health, National Institutes of Health, Bethesda, Maryland 20892-1109"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613351300200_R1","author":"DeLellis","year":"2004"},{"key":"2020071613351300200_R2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the First International Symposium.","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2020071613351300200_R3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613351300200_R4","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJM199906173402404","article-title":"Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.","volume":"340","author":"Eisenhofer","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071613351300200_R5","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613351300200_R6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/eje.1.01987","article-title":"Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.","volume":"153","author":"Huynh","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071613351300200_R7","first-page":"341","article-title":"Quantitative assessment of catecholamine secretion as a rational principle of anesthesia management in pheochromocytoma surgery.","volume":"30","author":"Schuttler","year":"1995","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2020071613351300200_R8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jnci\/93.8.648","article-title":"Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma.","volume":"93","author":"Pacak","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2020071613351300200_R9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/edrv-15-3-356","article-title":"Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma.","volume":"15","author":"Bravo","year":"1994","journal-title":"Endocr Rev"},{"key":"2020071613351300200_R10","first-page":"535","article-title":"Pheochromocytoma with elevated metanephrines as the only biochemical finding.","volume":"148","author":"Shawar","year":"1996","journal-title":"J La State Med Soc"},{"key":"2020071613351300200_R11","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors.","volume":"83","author":"Eisenhofer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613351300200_R12","first-page":"44","article-title":"Perioperative hypertensive crisis in clinically silent pheochromocytomas: report of four cases.","volume":"28","author":"Shen","year":"2005","journal-title":"Chang Gung Med J"},{"key":"2020071613351300200_R13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine.","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol Rev"},{"key":"2020071613351300200_R14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02067379","article-title":"The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.","volume":"16","author":"Ito","year":"1992","journal-title":"World J Surg"},{"key":"2020071613351300200_R15","first-page":"3009","article-title":"Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines.","volume":"80","author":"Eisenhofer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613351300200_R16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/cs0880533","article-title":"Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism?","volume":"88","author":"Eisenhofer","year":"1995","journal-title":"Clin Sci"},{"key":"2020071613351300200_R17","first-page":"193","article-title":"Blood pressure regulation in pheochromocytoma.","volume":"4","author":"Bravo","year":"1982","journal-title":"Hypertension"},{"key":"2020071613351300200_R18","first-page":"S43","article-title":"Adrenaline: a physiological metabolic regulatory hormone in humans","volume":"3","author":"Cryer","year":"1993","journal-title":"Int J Obes Relat Metab Disord 17 Suppl"},{"key":"2020071613351300200_R19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2169\/internalmedicine.44.222","article-title":"Pheochromocytoma presenting as recurrent hypotension and syncope.","volume":"44","author":"Ueda","year":"2005","journal-title":"Intern Med"},{"key":"2020071613351300200_R20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.RES.61.1.86","article-title":"Desensitization of postjunctional \u03b1 1- and \u03b1 2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma.","volume":"61","author":"Tsujimoto","year":"1987","journal-title":"Circ Res"},{"key":"2020071613351300200_R21","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1210\/endo-114-4-1272","article-title":"Desensitization of \u03b2-adrenergic receptors by pheochromocytoma.","volume":"114","author":"Tsujimoto","year":"1984","journal-title":"Endocrinology"},{"key":"2020071613351300200_R22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: state-of-the-art and future prospects.","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071613351300200_R23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/jcan.2002.124150","article-title":"Perioperative management of pheochromocytoma.","volume":"16","author":"Kinney","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2020071613351300200_R24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/bja\/85.1.44","article-title":"Phaeochromocytoma\u2013recent progress in its management.","volume":"85","author":"Prys-Roberts","year":"2000","journal-title":"Br J Anaesth"},{"key":"2020071613351300200_R25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","article-title":"Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.","volume":"26","author":"Prys-Roberts","year":"2002","journal-title":"World J Surg"},{"key":"2020071613351300200_R26","first-page":"1149","article-title":"Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients.","volume":"106","author":"Proye","year":"1989","journal-title":"Surgery"},{"key":"2020071613351300200_R27","first-page":"319","article-title":"Pheochromocytoma: issues in diagnosis, treatment.","volume":"23","author":"Young Jr","year":"1997","journal-title":"Compr Ther"},{"key":"2020071613351300200_R28","first-page":"290","article-title":"Preoperative pharmacological management of phaeochromocytoma.","volume":"64","author":"van der Horst-Schrivers","year":"2006","journal-title":"Neth J Med"},{"key":"2020071613351300200_R29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000074661","article-title":"Preoperative and surgical therapy in sporadic and familial pheochromocytoma.","volume":"31","author":"Brauckhoff","year":"2004","journal-title":"Front Horm Res"},{"key":"2020071613351300200_R30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2265.2006.02571.x","article-title":"Phaeochromocytomas presenting as acute crises after \u03b2 blockade therapy.","volume":"65","author":"Sibal","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613351300200_R31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archinte.1984.00350130201036","article-title":"Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma.","volume":"144","author":"Sloand","year":"1984","journal-title":"Arch Intern Med"},{"key":"2020071613351300200_R32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11864-001-0025-5","article-title":"Pheochromocytoma.","volume":"2","author":"Eigelberger","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"2020071613351300200_R33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0889-8529(18)30378-5","article-title":"Management of pheochromocytoma.","volume":"18","author":"Shapiro","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071613351300200_R34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0748-7983(03)00071-4","article-title":"Phaeochromocytoma\u2013views on current management.","volume":"29","author":"Williams","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"2020071613351300200_R35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3949\/ccjm.60.5.365","article-title":"Pheochromocytoma: current diagnosis and management.","volume":"60","author":"Manger","year":"1993","journal-title":"Cleve Clin J Med"},{"key":"2020071613351300200_R36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1196\/annals.1353.044","article-title":"Management and treatment of pheochromocytomas and paragangliomas.","volume":"1073","author":"Mannelli","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"2020071613351300200_R37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-59259-757-4_14","article-title":"Pheochromocytoma treatment","author":"Malchoff","year":"2004","journal-title":"In: Mansoor GA, ed. Secondary hypertension. Totowa, NJ: Humana Press;"},{"key":"2020071613351300200_R38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3949\/ccjm.57.7.613","article-title":"Perioperative management of 63 patients with pheochromocytoma.","volume":"57","author":"Boutros","year":"1990","journal-title":"Cleve Clin J Med"},{"key":"2020071613351300200_R39","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1517\/13543784.13.12.1579","article-title":"Recent developments in the therapy of phaeochromocytoma.","volume":"13","author":"Chew","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"2020071613351300200_R40","first-page":"245","article-title":"Can a patient be successfully prepared for pheochromocytoma surgery in three days? A case report.","volume":"73","author":"Jankovic","year":"2007","journal-title":"Minerva Anestesiol"},{"key":"2020071613351300200_R41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0310057X9802600212","article-title":"The preoperative management of phaeochromocytoma.","volume":"26","author":"Russell","year":"1998","journal-title":"Anaesth Intens Care"},{"key":"2020071613351300200_R42","first-page":"112","article-title":"Preoperative management of phaeochromocytoma\u2014a paediatric perspective.","volume":"27","author":"Hack","year":"1999","journal-title":"Anaesth Intensive Care"},{"key":"2020071613351300200_R43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-99-4-477","article-title":"Pheochromocytoma and prazosin.","volume":"99","author":"Nicholson Jr","year":"1983","journal-title":"Ann Intern Med"},{"key":"2020071613351300200_R44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/clpt.1982.141","article-title":"Prazosin and propranolol in preoperative management of pheochromocytoma.","volume":"32","author":"Cubeddu","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"2020071613351300200_R45","first-page":"191","article-title":"\u03b1 Blockade in preoperative preparation of patients with pheochromocytomas.","volume":"87","author":"Kocak","year":"2002","journal-title":"Int Surg"},{"key":"2020071613351300200_R46","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bja\/58.12.1453","article-title":"Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management.","volume":"58","author":"Hull","year":"1986","journal-title":"Br J Anaesth"},{"key":"2020071613351300200_R47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48 years with pheochromocytoma.","volume":"229","author":"Goldstein","year":"1999","journal-title":"Ann Surg"},{"key":"2020071613351300200_R48","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/1097-0142(19881201)62:11<2451::AID-CNCR2820621134>3.0.CO;2-Q","article-title":"Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patients.","volume":"62","author":"Samaan","year":"1988","journal-title":"Cancer"},{"key":"2020071613351300200_R49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1399-6576.1985.tb02303.x","article-title":"Influence of pre-operative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anaesthesia and surgery for phaeochromocytoma.","volume":"29","author":"Stenstrom","year":"1985","journal-title":"Acta Anaesthesiol Scand"},{"key":"2020071613351300200_R50","first-page":"1480","article-title":"Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center.","volume":"86","author":"Plouin","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613351300200_R51","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5347(01)61762-2","article-title":"Successful outcomes in pheochromocytoma surgery in the modern era.","volume":"161","author":"Ulchaker","year":"1999","journal-title":"J Urol"},{"key":"2020071613351300200_R52","first-page":"1064","article-title":"Plasma catecholamine changes during excision of pheochromocytoma.","volume":"104","author":"Newell","year":"1988","journal-title":"Surgery"},{"key":"2020071613351300200_R53","first-page":"147","article-title":"Treatment of pheochromocytoma with dilevalol.","volume":"18","author":"Yabe","year":"1987","journal-title":"J Med"},{"key":"2020071613351300200_R54","first-page":"233","article-title":"Use of labetalol during anesthesia for pheochromocytoma removal.","volume":"34","author":"Van Stratum","year":"1983","journal-title":"Acta Anaesthesiol Belg"},{"key":"2020071613351300200_R55","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/bmj.280.6227.1300-a","article-title":"Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.","volume":"280","author":"Reach","year":"1980","journal-title":"Br Med J"},{"key":"2020071613351300200_R56","first-page":"617","article-title":"Current status of labetalol and other agents that block both \u03b1- and \u03b2-blocking agents.","volume":"23","author":"Kanto","year":"1985","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"2020071613351300200_R57","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(78)90772-9","article-title":"Hypertensive response to labetalol in phaeochromocytoma.","volume":"1","author":"Briggs","year":"1978","journal-title":"Lancet"},{"key":"2020071613351300200_R58","first-page":"1862","article-title":"Pheochromocytoma and related tumors","author":"Keiser","year":"2001","journal-title":"In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia: W.B. Saunders Co.;"},{"key":"2020071613351300200_R59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00006231-199207000-00006","article-title":"A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).","volume":"13","author":"Solanki","year":"1992","journal-title":"Nucl Med Commun"},{"key":"2020071613351300200_R60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1536\/ihj.30.751","article-title":"Effectiveness of long-acting nifedipine in pheochromocytoma.","volume":"30","author":"Takahashi","year":"1989","journal-title":"Jpn Heart J"},{"key":"2020071613351300200_R61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(83)92250-X","article-title":"Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade.","volume":"2","author":"Serfas","year":"1983","journal-title":"Lancet"},{"key":"2020071613351300200_R62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00045415-200201000-00009","article-title":"Pheochromocytoma.","volume":"10","author":"Bravo","year":"2001","journal-title":"Cardiol Rev"},{"key":"2020071613351300200_R63","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(65)90062-0","article-title":"Inhibition of catecholamine synthesis in man with \u03b1-methyl-tyrosine, an inhibitor of tyrosine hydroxylase.","volume":"2","author":"Sjoerdsma","year":"1965","journal-title":"Lancet"},{"key":"2020071613351300200_R64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-198121020-00001","article-title":"\u03b1-Methyl-p-tyrosine: a review of its pharmacology and clinical use.","volume":"21","author":"Brogden","year":"1981","journal-title":"Drugs"},{"key":"2020071613351300200_R65","first-page":"449","article-title":"Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.","volume":"115","author":"Kuchel","year":"1990","journal-title":"J Lab Clin Med"},{"key":"2020071613351300200_R66","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.1997.00440290087009","article-title":"Metyrosine and pheochromocytoma.","volume":"157","author":"Steinsapir","year":"1997","journal-title":"Arch Intern Med"},{"key":"2020071613351300200_R67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199011000-00010","article-title":"Surgical management of pheochromocytoma with the use of metyrosine.","volume":"212","author":"Perry","year":"1990","journal-title":"Ann Surg"},{"key":"2020071613351300200_R68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3476(77)80467-8","article-title":"Childhood pheochromocytoma: treatment with \u03b1 methyl tyrosine for resistant hypertension.","volume":"91","author":"Robinson","year":"1977","journal-title":"J Pediatr"},{"key":"2020071613351300200_R69","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.","volume":"134","author":"Pacak","year":"2001","journal-title":"Ann Intern Med"},{"key":"2020071613351300200_R70","first-page":"230","article-title":"Preoperative treatment and survival of patients with pheochromocytomas.","volume":"86","author":"Sand","year":"1997","journal-title":"Ann Chir Gynaecol"},{"key":"2020071613351300200_R71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004311-200010000-00004","article-title":"Perioperative management of selected endocrine disorders.","volume":"38","author":"Graham","year":"2000","journal-title":"Int Anesthesiol Clin"},{"key":"2020071613351300200_R72","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/jcan.2002.124145","article-title":"Excision of adrenal pheochromocytoma and coronary artery bypass graft surgery with cardiopulmonary bypass.","volume":"16","author":"Balabaud-Pichon","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2020071613351300200_R73","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1055-3207(18)30244-8","article-title":"Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-up.","volume":"7","author":"Kebebew","year":"1998","journal-title":"Surg Oncol Clin N Am"},{"key":"2020071613351300200_R74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0025-7125(16)30088-8","article-title":"Pheochromocytoma. Update on diagnosis, localization, and management.","volume":"79","author":"Werbel","year":"1995","journal-title":"Med Clin North Am"},{"key":"2020071613351300200_R75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1196\/annals.1353.005","article-title":"Lack of symptoms in patients with histologic evidence of pheochromocytoma: a diagnostic challenge.","volume":"1073","author":"Cohen","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"2020071613351300200_R76","article-title":"Unmasking a phaeochromocytoma by drug therapy: incidence, prevention and management","author":"Eisenhofer","journal-title":"Drug Safety"},{"key":"2020071613351300200_R77","first-page":"11","article-title":"Food interacting with MAO inhibitors","volume-title":"Med Lett Drugs Ther","year":"1989"},{"key":"2020071613351300200_R78","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613351300200_R79","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1399-6576.2004.00416.x","article-title":"Predictive value of preoperative transthoracic echocardiography in patients undergoing adrenalectomy for pheochromocytoma.","volume":"48","author":"Devaux","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"2020071613351300200_R80","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.echo.2006.06.014","article-title":"Reduced myocardial contractility assessed by tissue Doppler echocardiography is associated with increased risk during adrenal surgery of patients with pheochromocytoma: report of a preliminary study.","volume":"19","author":"Meune","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"2020071613351300200_R81","first-page":"313","article-title":"The importance of high-dose \u03b1-receptor blockade for blood volume and hemodynamics in pheochromocytoma.","volume":"39","author":"Grosse","year":"1990","journal-title":"Anaesthesist"},{"key":"2020071613351300200_R82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1148\/radiology.202.1.8988215","article-title":"Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels.","volume":"202","author":"Mukherjee","year":"1997","journal-title":"Radiology"},{"key":"2020071613351300200_R83","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2214\/AJR.06.0827","article-title":"CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material.","volume":"188","author":"Bessell-Browne","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"2020071613351300200_R84","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1460-9592.2000.00504.x","article-title":"The perioperative management of children with phaeochromocytoma.","volume":"10","author":"Hack","year":"2000","journal-title":"Paediatr Anaesth"},{"key":"2020071613351300200_R85","first-page":"484","article-title":"Malignant recurrent pheochromocytoma during pregnancy: case report and review of the literature.","volume":"103","author":"Ellison","year":"1988","journal-title":"Surgery"},{"key":"2020071613351300200_R86","first-page":"2501","article-title":"Pheochromocytoma","author":"Pacak","year":"2006","journal-title":"In: DeGroot LJ, Jamenson JL, eds. Endocrinology. 5th ed. Philadelphia: Elsevier Saunders;"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/11\/4069\/9051006\/jcem4069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/11\/4069\/9051006\/jcem4069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:10:56Z","timestamp":1594930256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/11\/4069\/2597882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1720","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}